CCND1 and larynx cancer: Furthermore, associated with the existence of LSCC located in the supraglottic larynx, highly invasive (T3 and T4) malignant neoplasms of the larynx and tumors being at an advanced clinical stage (III and IV) are CCND1 immunopositivities.